Skip to content

Climb Bio, Inc. CLYM Total Current Assets

Total Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$27.21B-11.6%
Amgen logo
AmgenAMGN
$31.48B+16.9%
Vera Therapeutics logo
Vera TherapeuticsVERA
$615.8M+1.6%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$241.73M-2.4%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$361.41M+13.7%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$318.52M+312%

Other financials

Income statement

See full
Operating income-$15.2M+33.9%
Net income-$13.7M+34.0%
EPS (diluted)-$0.20+35.5%

Balance sheet

See full
Cash & equivalents$8.4M-71.2%
Total debt$479.0K+1.1%
Total equity$148.1M-23.4%
Total assets$152.4M-24.1%

Cash flow

See full
Operating cash flow-$14.4M+6.8%
CapEx$109.0K
Free cash flow-$15.6M-183%

Valuation

See full
Market cap$724.95M+787%
Enterprise value$717.07M+1,247%

Returns & leverage

See full
Return on equity-30.9%-10.3pp
Debt / equity0.0×
Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Climb Bio, Inc.'s total current assets?
Climb Bio, Inc. (CLYM) reported total current assets of $113.4M in Q1 2026.
How has Climb Bio, Inc.'s total current assets changed year-over-year?
Climb Bio, Inc.'s total current assets increased by 13.1% year-over-year, from $100.28M to $113.4M.
What is the long-term trend for Climb Bio, Inc.'s total current assets?
Over 5 years (2020 to 2025), Climb Bio, Inc.'s total current assets has grown at a 36.9% compound annual growth rate (CAGR), from $22M to $105.85M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.